Related references
Note: Only part of the references are listed.AKT1 Mutations in Peripheral Bronchiolar Papilloma Glandular Papilloma and Mixed Squamous Cell and Glandular Papilloma Is Distinct From Bronchiolar Adenoma
Eiichi Sasaki et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Bronchiolar Adenoma/Pulmonary Ciliated Muconodular Papillary Tumor Potential Pitfall on Frozen Sections
Hemlata Shirsat et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Gross Specimen Handling Procedures Do Not Impact the Occurrence of Spread Through Air Spaces (STAS) in Lung Cancer
Jasna Metovic et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
Carl M. Gay et al.
CANCER CELL (2021)
Genetic Ancestry Contributes to Somatic Mutations in Lung Cancers from Admixed Latin American Populations
Jian Carrot-Zhang et al.
CANCER DISCOVERY (2021)
Small-cell lung cancer
Charles M. Rudin et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Morphological, immunohistochemical, and genetic analyses of bronchiolar adenoma and its putative variants
Jinchen Shao et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype
Taofeek K. Owonikoko et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Ahmet Sezer et al.
LANCET (2021)
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah Blythe Doroshow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples
Katharina Kriegsmann et al.
BMC CANCER (2021)
Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
Jason C. Chang et al.
CLINICAL CANCER RESEARCH (2021)
Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling
Soo-Ryum Yang et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Ciliated muconodular papillary tumor/bronchiolar adenoma of the lung
Tzu-Hang Kao et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2021)
EBUS-TBNA Cytological Samples for Comprehensive Molecular Testing in Non-Small Cell Lung Cancer
Roberto Martin-Deleon et al.
CANCERS (2021)
Counting mitoses: SI(ze) matters!
Ian A. Cree et al.
MODERN PATHOLOGY (2021)
The Role of Histologic Grading and Ki-67 Index in Predicting Outcomes in Pulmonary Carcinoid Tumors
Josephine K. T. Dermawan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms
Naomi Oka et al.
NEUROENDOCRINOLOGY (2020)
A Semiquantitative Scoring System May Allow Biopsy Diagnosis of Pulmonary Large Cell Neuroendocrine Carcinoma Experience With Tissue Microarrays
Marina K. Baine et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)
Genomic Underpinnings of Tumor Behavior in In Situ and Early Lung Adenocarcinoma
Jun Qian et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
Natasha Rekhtman et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
K. Park et al.
ANNALS OF ONCOLOGY (2020)
Pulmonary peripheral glandular papilloma and mixed squamous cell and glandular papilloma frequently harbour the BRAF V600E mutation
Dong-Liang Lin et al.
HISTOPATHOLOGY (2020)
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
Nasser H. Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
John T. Poirier et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
Sylvie Lantuejoul et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Genomic landscape of lung adenocarcinoma in East Asians
Jianbin Chen et al.
NATURE GENETICS (2020)
Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology
Jerome Cros et al.
NEUROENDOCRINOLOGY (2020)
Non-small cell lung carcinomas with CTNNB1 (beta-catenin) mutations: A clinicopathological study of 26 cases
Vincent Thomas de Montpreville et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
Recent eUpdate to the ESMO Clinical Practice Guidelines on early and locally advanced non-small-cell lung cancer (NSCLC)
G. Pentheroudakis
ANNALS OF ONCOLOGY (2020)
The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer
Adamj. Schoenfeld et al.
CLINICAL CANCER RESEARCH (2020)
Both the presence of a micropapillary component and the micropapillary predominant subtype predict poor prognosis after lung adenocarcinoma resection: a meta-analysis
Wei Wang et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2020)
Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis
Marina K. Baine et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
Andre L. Moreira et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report
Sarah M. Pearsall et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms
M. Rubino et al.
LUNG CANCER (2020)
Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma
Chen Yang et al.
MODERN PATHOLOGY (2020)
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
Marina K. Baine et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
The Isoform Matters in NUT Carcinoma: A Diagnostic Pitfall of p40 Immunohistochemistry
Kohei Matsuda et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer
Yi-Long Wu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer
Juergen Wolf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Reassessing the SCLC Subtypes
Yasushi Yatabe
JOURNAL OF THORACIC ONCOLOGY (2020)
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
Sylvie Lantuejoul et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2020)
Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis
Takashi Eguchi et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Procedure-Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis
Sarina Bains et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms
Eric Baudin et al.
NEUROENDOCRINOLOGY (2019)
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors
Patrick Robelin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Yasushi Yatabe et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices
Natasha Rekhtman et al.
MODERN PATHOLOGY (2019)
Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer
Shiwang Wen et al.
ONCOLOGIST (2019)
Prognostic Impact of Tumor Spread Through Air Spaces in Non-small Cell Lung Cancers: a Meta-Analysis Including 3564 Patients
Huining Liu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces
Kyuichi Kadota et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
J. Mazieres et al.
ANNALS OF ONCOLOGY (2019)
Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens
Pasquale Pisapia et al.
CANCER CYTOPATHOLOGY (2019)
Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements
Jason C. Chang et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung
Rania G. Aly et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations
Michele Simbolo et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
Tony S. K. Mok et al.
LANCET (2019)
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma
Xin Hu et al.
NATURE COMMUNICATIONS (2019)
Two cases of lung neuroendocrine carcinoma with carcinoid morphology
Kenji Inafuku et al.
DIAGNOSTIC PATHOLOGY (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids
N. Alcala et al.
NATURE COMMUNICATIONS (2019)
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
Nicolas Marcoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Clinicopathological Profiling of Lung Carcinoids with a Ki67 Index >20%
Atsuko Kasajima et al.
NEUROENDOCRINOLOGY (2019)
Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options
Philipp Jurmeister et al.
LUNG CANCER (2019)
Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept
Giuseppe Pelosi et al.
CLINICAL PATHOLOGY (2019)
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
Charles M. Rudin et al.
NATURE REVIEWS CANCER (2019)
Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined French-Italian Retrospective Multicenter Study
Francesca Marciello et al.
NEUROENDOCRINOLOGY (2018)
Bronchiolar Adenoma Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases
Jason C. Chang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Tumor Spread Through Air Spaces Identifies a Distinct Subgroup With Poor Prognosis in Surgically Resected Lung Pleomorphic Carcinoma
Shintaro Yokoyama et al.
CHEST (2018)
Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis
Yonggang Yuan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with 131I-MIBG
Ari Kane et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
NCCN Guidelines® Insights Neuroendocrine and Adrenal Tumors, Version 2.2018 Featured Updates to the NCCN Guidelines
Manisha H. Shah et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management
Jules L. Derks et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
Neal I. Lindeman et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy
Ming Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients
Simon R. Turner et al.
LUNG CANCER (2018)
Hyalinizing clear cell carcinoma of the bronchial glands: presentation of three cases and pathological comparisons with salivary gland counterparts and bronchial mucoepidermoid carcinomas
Manabu Takamatsu et al.
MODERN PATHOLOGY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors
Julie George et al.
NATURE COMMUNICATIONS (2018)
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Ferdinandos Skoulidis et al.
CANCER DISCOVERY (2018)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Planchard et al.
ANNALS OF ONCOLOGY (2018)
So-called non-classic ciliated muconodular papillary tumors: a comprehensive comparison of the clinicopathological and molecular features with classic ciliated muconodular papillary tumors
Qiang Zheng et al.
HUMAN PATHOLOGY (2018)
Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma
Koji Kameda et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas
Naoya Miyashita et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal
Guido Rindi et al.
MODERN PATHOLOGY (2018)
Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma
Song Gao et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome
Jules L. Derks et al.
CLINICAL CANCER RESEARCH (2018)
The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients with Targetable Mutations-The Lung Cancer Mutation Consortium (LCMC2)
Dara L. Aisner et al.
CLINICAL CANCER RESEARCH (2018)
Limited additive value of the Ki-67 proliferative index on patient survival in World Health Organization-classified pulmonary carcinoids
Dorian R. A. Swarts et al.
HISTOPATHOLOGY (2017)
Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy
Jonathan E. Leeman et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Use of of Oncogenic Driver Mutations in Staging of Multiple Primary Lung Carcinomas: A Single-Center Experience
Ramsey Asmar et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer-Specific Death in Squamous Cell Carcinoma
Shaohua Lu et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities
Akihiko Yoshida et al.
MODERN PATHOLOGY (2017)
SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior
Jennifer L. Sauter et al.
MODERN PATHOLOGY (2017)
A case of anaplastic lymphoma kinase (ALK)-positive ciliated muconodular papillary tumor (CMPT) of the lung
Ryo Taguchi et al.
PATHOLOGY INTERNATIONAL (2017)
Distinctive pathological and clinical features of lung carcinoids with high proliferation index
Caterina Marchio et al.
VIRCHOWS ARCHIV (2017)
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
Emmet J. Jordan et al.
CANCER DISCOVERY (2017)
Differences between low and high grade fetal adenocarcinoma of the lung: a clinicopathological and molecular study
Jing Zhang et al.
JOURNAL OF THORACIC DISEASE (2017)
Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas
Daisuke Matsubara et al.
CANCER SCIENCE (2017)
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Emiko Udo et al.
DIAGNOSTIC PATHOLOGY (2017)
High-grade Neuroendocrine Carcinoma of the Lung With Carcinoid Morphology A Study of 12 Cases
Anne Marie Quinn et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis
Yue Zhao et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Biomarker Testing in Lung Carcinoma Cytology Specimens A Perspective From Members of the Pulmonary Pathology Society
Sinchita Roy-Chowdhuri et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets
Natasha Rekhtman et al.
CLINICAL CANCER RESEARCH (2016)
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung
David H. Hwang et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Frequent BRAF or EGFR Mutations in Ciliated Muconodular Papillary Tumors of the Lung
Tsugumasa Kamata et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Comprehensive Characterization of Oncogenic Drivers in Asian Lung Adenocarcinoma
Shiyong Li et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
David Planchard et al.
LANCET ONCOLOGY (2016)
Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging
Frank Schneider et al.
MODERN PATHOLOGY (2016)
Ciliated Muconodular Papillary Tumors of the Lung A Clinicopathologic Analysis of 10 Cases
Tsugumasa Kamata et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma
Arne Warth et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
M. E. Caplin et al.
ANNALS OF ONCOLOGY (2015)
A Prospective Clinical Trial of Telecytopathology for Rapid Interpretation of Specimens Obtained During Endobronchial Ultrasound-Fine Needle Aspiration
Matthew J. Bott et al.
ANNALS OF THORACIC SURGERY (2015)
Rapid on-site evaluation of EBUS-TBNA specimens of lymph nodes: Comparative analysis and recommendations for standardization
Susanne K. Jeffus et al.
CANCER CYTOPATHOLOGY (2015)
Preanalytic Parameters in Epidermal Growth Factor Receptor Mutation Testing for Non-Small Cell Lung Carcinoma: A Review of Cytologic Series
Gilda da Cunha Santos et al.
CANCER CYTOPATHOLOGY (2015)
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung
Hyo Sup Shim et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
EGFR Mutation Testing Practices within the Asia Pacific Region Results of a Multicenter Diagnostic Survey
Yasushi Yatabe et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas
Kyuichi Kadota et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
Francois Le Loarer et al.
NATURE GENETICS (2015)
Response to MET Inhibitors in Patients with Stage IV Lung Adenocarcinomas Harboring MET Mutations Causing Exon 14 Skipping
Paul K. Paik et al.
CANCER DISCOVERY (2015)
MAP2K1 (MEK1) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking
Maria E. Arcila et al.
CLINICAL CANCER RESEARCH (2015)
Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma
Seung Eun Lee et al.
MODERN PATHOLOGY (2015)
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma
Takashi Nakaoku et al.
CLINICAL CANCER RESEARCH (2014)
Grading the neuroendocrine tumors of the lung: an evidence-based proposal
G. Rindi et al.
ENDOCRINE-RELATED CANCER (2014)
Sample Features Associated with Success Rates in Population-Based EGFR Mutation Testing
Carolyn J. Shiau et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: A comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
Yunjian Pan et al.
LUNG CANCER (2014)
On the relevance of a testing algorithm for the detection of ROS1-rearranged lung adenocarcinomas
Lenaig Mescam-Mancini et al.
LUNG CANCER (2014)
Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer
Alice T. Shaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ciliated muconodular papillary tumor of the lung: A newly defined peripheral pulmonary tumor with conspicuous mucin pool mimicking colloid adenocarcinoma: A case report and review of literature
Hao-Wen Chuang et al.
PATHOLOGY INTERNATIONAL (2014)
The Influence of Rapid Onsite Evaluation on the Adequacy Rate of Fine-Needle Aspiration Cytology A Systematic Review and Meta-Analysis
Robert L. Schmidt et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
HNF4α as a Marker for Invasive Mucinous Adenocarcinoma of the Lung
Masato Sugano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Diagnosis of Lung Cancer in Small Biopsies and Cytology Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification
William D. Travis et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Characteristics of Lung Cancers Harboring NRAS Mutations
Kadoaki Ohashi et al.
CLINICAL CANCER RESEARCH (2013)
Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients-Based on a hospital study in China
Z. Song et al.
EJSO (2013)
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Gillian Ellison et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung Potential Parameters for a Grading System
Jan H. von der Thusen et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Correlation of Mutation Status and Survival with Predominant Histologic Subtype According to the New IASLC/ATS/ERS Lung Adenocarcinoma Classification in Stage III (N2) Patients
Prudence A. Russell et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations Analysis of 440 Japanese Patients
Akihiko Yoshizawa et al.
JOURNAL OF THORACIC ONCOLOGY (2013)
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma
Natasha Rekhtman et al.
MODERN PATHOLOGY (2013)
Nkx2-1 Represses a Latent Gastric Differentiation Program in Lung Adenocarcinoma
Eric L. Snyder et al.
MOLECULAR CELL (2013)
The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
Koji Tsuta et al.
LUNG CANCER (2013)
Acquisition and Processing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Specimens in the Era of Targeted Lung Cancer Chemotherapy
William Bulman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
Snjezana Dogan et al.
CLINICAL CANCER RESEARCH (2012)
RET Fusions Define a Unique Molecular and Clinicopathologic Subtype of Non-Small-Cell Lung Cancer
Rui Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors
Ann E. Walts et al.
MODERN PATHOLOGY (2012)
RET, ROS1 and ALK fusions in lung cancer
Kengo Takeuchi et al.
NATURE MEDICINE (2012)
Primary Pulmonary Myxoid Sarcoma With EWSR1-CREB1 Fusion: A New Tumor Entity
Khin Thway et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
Paul K. Paik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing
Natasha Rekhtman et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
Akihiko Yoshizawa et al.
MODERN PATHOLOGY (2011)
Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
Peh Sun Loo et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Unique Clinicopathologic Features Characterize ALK-Rearranged Lung Adenocarcinoma in the Western Population
Scott J. Rodig et al.
CLINICAL CANCER RESEARCH (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Epidermal growth factor receptor gene mutations in atypical adenomatous hyperplasias of the lung
Yuji Sakuma et al.
MODERN PATHOLOGY (2007)
Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens - A major pitfall in the management of lung cancer patients
G Pelosi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Primary mucinous (so-called colloid) carcinomas of the lung -: A clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression
G Rossi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Aberrant nuclear localization and gene mutation of β-catenin in low-grade adenocarcinoma of fetal lung type:: Up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules
Y Nakatani et al.
MODERN PATHOLOGY (2002)
Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category
SL Edwards et al.
JOURNAL OF CLINICAL PATHOLOGY (2000)
Share Paper
